Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000194341 | SCV000248656 | uncertain significance | not specified | 2015-02-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002317702 | SCV000850426 | likely benign | Inborn genetic diseases | 2017-03-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001689729 | SCV001908111 | benign | not provided | 2021-04-21 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001689729 | SCV002354682 | benign | not provided | 2024-01-06 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001689729 | SCV004142345 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | RAI1: BP4, BP7 |
Prevention |
RCV003937713 | SCV004755652 | benign | RAI1-related condition | 2020-10-26 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |